Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 105 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

7%

7 trials in Phase 3/4

Results Transparency

4%

2 of 50 completed trials have results

Key Signals

14 recruiting2 with results

Enrollment reporting

Analytics

N/A
29(63.0%)
Phase 4
5(10.9%)
Phase 2
5(10.9%)
Phase 2/3
3(6.5%)
Phase 3
2(4.3%)
Phase 1/2
1(2.2%)
Phase 1
1(2.2%)
46Total
N/A(29)
Phase 4(5)
Phase 2(5)
Phase 2/3(3)
+3 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (105)

Showing 20 of 105 trials
NCT07585890Recruiting

Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe

Role: collaborator

NCT07866144Completed

Prediction of Adverse Events From Non-PCI Coronary Plaques Using Machine Learning

Role: lead

NCT04878133Not ApplicableCompleted

OCT Guided vs COmplete Pci in patieNts With sT Segment Elevation myocArdial infarCtion and mulTivessel Disease

Role: lead

NCT06855056Completed

Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis

Role: collaborator

NCT07072286Recruiting

RELIEVED (REgionaL anesthesIa PElVic fracturEs stuDy) Study. Regional Anesthesia (RA) Techniques for Pain Management in Pelvic Fractures: A Prospective, Monocentric, Pilot Cohort Study.

Role: lead

NCT07017192Not ApplicableRecruiting

OPPOSED (anteriOr hiP arthroPlasty regiOnal aneSthEsia stuDy) Study

Role: lead

NCT06409832Recruiting

RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment

Role: collaborator

NCT06409845Completed

Effectiveness and Tolerability of Eptinezumab

Role: collaborator

NCT05750706Completed

Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative

Role: collaborator

NCT07535125Not Yet Recruiting

IPEX Study: Pancreatic Exocrine Insufficiency as a Functional Marker of Disease Progression in Patients With IPMN

Role: lead

NCT07387185Recruiting

AI System for Detection and Characterization of Chronic Enteropathies

Role: collaborator

NCT07360964Not ApplicableActive Not Recruiting

Clear Cell Chondrosarcoma in Italy

Role: collaborator

NCT05903027Recruiting

Gepant treAtments: EffectIveNess and tolERability (GAINER)

Role: collaborator

NCT05903040Completed

Ditan Acute tReatments: Effectiveness and Tolerability (DART)

Role: collaborator

NCT06414044Active Not Recruiting

Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients

Role: collaborator

NCT07245524Completed

PeriOPerative Spine Surgery COntrol Pain (POPSSCOP) Study: Intrathecal Morphine vs Erector Spinae Plane Block for Postoperative Pain Management in Spinal Fusion

Role: lead

NCT07061379Recruiting

Patient Reported Outcome Measurements (PROMs) Impact on Clinical Outcome in firsT Line settIng Non- Small-Cell Lung Cancer (NSCLC) According to Chemo- Immunotherapy reGimen

Role: collaborator

NCT02638142Recruiting

Loop Diuretic Therapy in Acutely Decompensated Heart Failure

Role: collaborator

NCT06318598Recruiting

Biomarker-driven Phenotypic Dissection of Amyotrophic Lateral Sclerosis

Role: collaborator

NCT06917924Recruiting

A Patient-tailored Genetic/Biomarker/iPSC Combined Approach in ALS - PERMEALS

Role: lead